VANRAFIA
LIVE

Serial Number

79238110

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 30, 2018

Add to watchlist:

No watchlists yet
View on USPTO

VANRAFIA Trademark

Serial Number: 79238110 • Registration: 5640110

VANRAFIA is a trademark filed by NOVARTIS AG on May 30, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 30, 2018

Registration Date

January 1, 2019

Published for Opposition

October 16, 2018

Goods & Services

[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; ] pharmaceutical preparations for the prevention and treatment of kidney diseases [ ; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 21, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Aug 21, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Aug 21, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 11, 2025 APRE
TEAS SECTION 71 RECEIVED
May 16, 2025 ES71
INTERNATIONAL REGISTRATION RENEWED
Aug 13, 2024 RNWL
NOTIFICATION PROCESSED BY IB
Apr 12, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Feb 8, 2019 FICS
FINAL DISPOSITION PROCESSED
Feb 8, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jan 31, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Jan 1, 2019 R.PR
NOTIFICATION PROCESSED BY IB
Nov 9, 2018 GPNX
PUBLISHED FOR OPPOSITION
Oct 16, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 26, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 26, 2018 OP2R
NOTICE OF PUBLICATION
Sep 26, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 10, 2018 CNSA
ASSIGNED TO EXAMINER
Sep 7, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 14, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 3, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Aug 2, 2018 SDRC